Veltassa 8.4 GM powder packet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E8A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,963
Award facts
- Contract value 100% obligated
- $70,962.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Veltassa 8.4 GM powder packets (30-count units) with a contract value of $70,962.63. This firm fixed-price delivery order is non-competitive and carries an ultimate completion date of January 13, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract awards demonstrate extensive capability in supplying a comprehensive range of pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs, vaccines, and medical supplies. The Veltassa order represents a routine pharmaceutical supply transaction within the company's established federal contracting relationship with the Defense Logistics Agency, supporting the department's medical supply chain requirements for potassium binder medications used in the treatment of hyperkalemia.
Quick answers
Who was awarded contract SPE2DR26F4E8A?
SPE2DR26F4E8A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4E8A worth?
The government has obligated $70,963 on SPE2DR26F4E8A.
Is contract SPE2DR26F4E8A an order under another contract?
Yes. SPE2DR26F4E8A is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E8A competed?
The extent of competition for SPE2DR26F4E8A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award